Daewoong Pharma (069620) — Tangible Net Worth Ratio
Daewoong Pharma (069620) has a Tangible Net Worth Ratio of 63.0% as of September 2025. This metric is calculated by deducting intangible assets (₩371.20 Billion) from net assets (₩1.00 Trillion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of Daewoong Pharma to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Daewoong Pharma Tangible Net Worth Ratio (2007–2024)
This chart shows how Daewoong Pharma's Tangible Net Worth Ratio has changed across 16 annual periods from 2007 to 2024. As of September 2025, the ratio stands at 63.0%, reflecting net assets of ₩1.00 Trillion with intangible assets of ₩371.20 Billion KRW. See 069620 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Daewoong Pharma (2007–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Daewoong Pharma from 2007 to 2024, covering 16 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Daewoong Pharma stock valuation.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 69.2% | ₩926.98 Billion | ₩285.86 Billion | ₩1.98 Trillion | ▼ -5.1 pp |
| 2023 | 74.3% | ₩802.97 Billion | ₩206.67 Billion | ₩1.57 Trillion | ▲ +1.9 pp |
| 2022 | 72.3% | ₩741.22 Billion | ₩205.16 Billion | ₩1.56 Trillion | ▼ -4.3 pp |
| 2021 | 76.6% | ₩702.41 Billion | ₩164.32 Billion | ₩1.42 Trillion | ▼ -6.4 pp |
| 2020 | 83.0% | ₩695.25 Billion | ₩117.89 Billion | ₩1.37 Trillion | ▼ -0.6 pp |
| 2019 | 83.7% | ₩635.92 Billion | ₩103.84 Billion | ₩1.25 Trillion | ▼ -1.7 pp |
| 2018 | 85.4% | ₩607.81 Billion | ₩88.73 Billion | ₩1.21 Trillion | ▲ +3.3 pp |
| 2017 | 82.1% | ₩631.54 Billion | ₩113.13 Billion | ₩1.21 Trillion | ▼ -3.0 pp |
| 2016 | 85.1% | ₩604.55 Billion | ₩90.15 Billion | ₩1.14 Trillion | ▼ -5.8 pp |
| 2015 | 90.9% | ₩580.24 Billion | ₩52.65 Billion | ₩944.53 Billion | ▼ -2.2 pp |
| 2014 | 93.1% | ₩455.51 Billion | ₩31.41 Billion | ₩694.26 Billion | ▼ -0.6 pp |
| 2013 | 93.7% | ₩437.96 Billion | ₩27.76 Billion | ₩579.01 Billion | ▲ +1.3 pp |
| 2012 | 92.4% | ₩386.59 Billion | ₩29.52 Billion | ₩482.34 Billion | ▼ -1.1 pp |
| 2011 | 93.5% | ₩362.42 Billion | ₩23.73 Billion | ₩498.46 Billion | ▼ -3.2 pp |
| 2008 | 96.7% | ₩278.85 Billion | ₩9.30 Billion | ₩486.24 Billion | ▼ -2.2 pp |
| 2007 | 98.8% | ₩269.57 Billion | ₩3.17 Billion | ₩392.81 Billion | — |